TY - JOUR AU - Wu, Shuai AU - Luo, Wenfan AU - Wu, Yin AU - Chen, Hongjie AU - Peng, Jie PY - 2020 DA - 2020/04/21 TI - HBsAg quantification predicts off-treatment response to interferon in chronic hepatitis B patients: a retrospective study of 250 cases JO - BMC Gastroenterology SP - 121 VL - 20 IS - 1 AB - For chronic hepatitis B (CHB) patients without willingness to extend the routine duration of interferon (IFN) therapy, it is important to identify patients who will benefit from treatment cessation. Hepatitis B surface antigen (HBsAg) quantification is recommended for management of IFN therapy. At present, the understanding on end-of-treatment (EOT) HBsAg level predicting post-treatment response to IFN is still finite. SN - 1471-230X UR - https://doi.org/10.1186/s12876-020-01263-6 DO - 10.1186/s12876-020-01263-6 ID - Wu2020 ER -